Expression of the multiple sclerosis associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D

被引：0
|
作者：
Ebers, George [1 ]
Ramagopalan, Sreeram V. [1 ]
Maugeri, Narelle J. [1 ]
Dyment, David A. [1 ]
Lincoln, Matthew R. [1 ]
Orton, Sarah-Michelle [1 ]
DeLuca, Gabriele [1 ]
Herrera, Blanca M. [1 ]
Handunnetthi, Lahiru [1 ]
Chao, Micbael J. [1 ]
Wicks, Kate [1 ]
Knight, Julian C. [1 ]
Sadounick, A. Dessa [2 ]
机构：
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
ANNALS OF NEUROLOGY | 2008年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [41] HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis
    Fusco, C
    Andreone, V
    Cappola, G
    Luongo, V
    Guerini, F
    Pace, E
    Florio, C
    Pirozzi, G
    Lanzillo, R
    Ferrante, P
    Vivo, P
    Mini, M
    Macrì, M
    Orefice, G
    Lombardi, ML
    [J]. NEUROLOGY, 2001, 57 (11) : 1976 - 1979
  • [42] HLA-DRB1 and disease outcome in multiple sclerosis
    Weatherby, SJM
    Thomson, W
    Pepper, L
    Donn, R
    Worthington, J
    Mann, CLA
    Davies, MB
    Fryer, MB
    Fryer, AA
    Boggild, MD
    Young, CA
    Jones, PW
    Strange, RC
    Ollier, WER
    Hawkins, CP
    [J]. JOURNAL OF NEUROLOGY, 2001, 248 (04) : 304 - 310
  • [43] HLA-DRB1 and disease outcome in multiple sclerosis
    S. J. M. Weatherby
    W. Thomson
    L. Pepper
    R. Donn
    J. Worthington
    C. L. A. Mann
    M. B. Davies
    A. A. Fryer
    M. D. Boggild
    C. A. Young
    P. W. Jones
    R. C. Strange
    W. E. R. Ollier
    C. P. Hawkins
    [J]. Journal of Neurology, 2001, 248 : 304 - 310
  • [44] HLA-DRB1 and prognosis of multiple sclerosis in France
    Yaouanq, J
    Drapier, S
    Leray, E
    Le Page, E
    Chaperon, J
    Edan, G
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S118 - S118
  • [45] HLA-DRB1 and month of birth in multiple sclerosis
    Ramagopalan, S. V.
    Link, J.
    Byrnes, J. K.
    Dyment, D. A.
    Giovannoni, G.
    Hintzen, R. Q.
    Sundqvist, E.
    Kockum, I.
    Smestad, C.
    Lic, B. A.
    Harbo, H. F.
    Padyukov, L.
    Alfredsson, L.
    Olsson, T.
    Sadovnick, A. D.
    Hillert, J.
    Ebers, G. C.
    [J]. NEUROLOGY, 2009, 73 (24) : 2107 - 2111
  • [46] Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin
    Nakao, S
    Takami, A
    Sugimori, N
    Ueda, M
    Shiobara, S
    Matsuda, T
    Mizoguchi, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (01) : 155 - 158
  • [47] HLA-DRB1 and multiple sclerosis in a spanish population
    Romero-Pinel, L.
    Pujal, J. M.
    Gubieras, L.
    Matas, E.
    Bau, L.
    Martinez-Yelamos, S.
    Arbizu, T.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S35 - S36
  • [48] Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis
    delaConcha, EG
    Arroyo, R
    Crusius, JBA
    Campillo, JA
    Martin, C
    deSeijas, E
    Pena, AS
    Claveria, LE
    FernandezArquero, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) : 172 - 178
  • [49] Human MHC-class II drives anti-FVIII immune responses in humanized HLA-DRB1*1501 hemophilic mice
    Reipert, B.
    Steinitz, K.
    Sasgary, M.
    Schuster, M.
    Ahmad, R.
    Schwarz, H.
    [J]. HAEMOPHILIA, 2008, 14 : 43 - 43
  • [50] HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis
    Cournu-Rebeix, I.
    Genin, E.
    Leray, E.
    Babron, M-C
    Cohen, J.
    Gout, C.
    Alizadeh, M.
    Perdry, H.
    Semana, G.
    Brassat, D.
    Clerget-Darpoux, F.
    Yaouanq, J.
    Edan, G.
    Rosenheim, M.
    Fontaine, B.
    [J]. GENES AND IMMUNITY, 2008, 9 (06) : 570 - 574
12345